Testimony, Comments and Briefs


2018 Briefs

  • Health and medical organization amicus brief urging the U.S. Supreme Court to reinstate the injunctions against implementation of the Proclamation barring individuals from entering the U.S. on the basis of nationality (March 27)
  • Health organization brief to the U.S. Court of Appeals for the Second Circuit in support of requiring discharge planning for to individuals with serious mental illness held in government custody (Feb. 20)
  • Health organization brief supporting a decision directing the Environmental Protection Agency to revoke all tolerances for the pesticide chlorpyrifos (Feb. 13)
  • Health organization brief in support of Planned Parenthood before the U.S. Court of Appeals for the Eight Circuit (Feb. 1)

2017 Testimony

  • APHA testimony to the House Appropriations Subcommittee on Labor, HHS, Education and Related Agencies regarding FY 2018 funding for CDC and HRSA (March 8)


  • Organization comments to CMS regarding proposed changes to the Essential Health Benefits standard by the Department of Health and Human Services (Nov. 27)
  • APHA comments to the Department of Health and Human Services on its draft Strategic Plan FY 2018 – 2022 (Oct. 25)
  • Collaborative for Effective Prescription Opioid Policies comments regarding the Opioid Commission's interim report (Oct. 6)
  • Health organization comments to U.S. EPA and U.S. Army Corps of Engineers opposing proposal to roll back Clean Water Act rule (Sept. 26)
  • APHA comments to EPA regarding scopes of risk evaluations for 10 chemicals under the amended Toxic Substances Control Act (Sept. 18)
  • Organization comments regarding the Commission on Combating Drug Addiction and the Opioid Crisis interim report (Sept. 6)
  • Health organization comments regarding EPA's proposed delay of methane emission standards for oil and natural gas facilities (Aug. 9)
  • Organization comments to the Food and Drug Administration opposing delay or weakening of the menu labeling rule (Aug. 2)
  • APHA comments to the Occupation Health and Safety Administration regarding a proposed rule to delay the compliance date for the regulation to improve tracking of occupational injuries and illnesses (July 13)
  • Organization comments to FDA on tobacco product standard for N-Nitrosonornicotine level in finished smokeless tobacco products (July 10)
  • APHA comments to the Food and Drug Administration opposing delay or weakening of the menu labeling rule (June 28)
  • Organization comments to the Department of Housing and Urban Development in support of the Smokefree Public Housing Rule (June 14)
  • Organization comments requesting that the U.S. Trade Representative ensures that a modernized NAFTA provides the protections necessary to enable all countries party to the agreement to adopt measures to protect their citizens from the death and disease caused by tobacco products without facing risk of litigation by tobacco companies (June 12)
  • APHA comments concerning the U.S. Environmental Protection Agency’s request for public comment on regulations that may be appropriate for repeal, replacement or modification (May 12)
  • Health organization comments urging the U.S. EPA to follow the Congressionally-established framework in the Clean Air Act to ensure that all areas of the U.S. meet and maintain the 2015 ozone standard as expeditiously as practicable (Feb. 13)
  • Health organization comments to the Office of Management and Budget raising concerns about an executive order that could jeopardize regulations that safeguard safety and health (Feb. 10)

2017 Briefs

More Testimony, Comments and Briefs